On heels of Genome Compiler buy, Twist Bioscience raises small round
Twist Bioscience's platform centers around scaling DNA synthesis, building genetic sequences out at a fraction of the price of what they've historically cost.
Scaling DNA synthesis 10,000-fold: Twist Bioscience raises $81M
Twist Bioscience has plans to enter the pharmaceutical industry with its powerful DNA synthesis technology.
presented by
Closing the Quality-Affordability Gap in Workplace Mental Health
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.